Classification of Products as Pharmaceutical Products under the Pharmacy and Poisons Ordinance (Cap. 138)

Introduction

The Pharmacy and Poisons Ordinance (Chapter 138) is Hong Kong's primary legislation that governs the control and regulation of medicinal products, poisons, and dangerous drugs. A critical aspect of this ordinance is the classification system that determines how different products are regulated based on their therapeutic purpose, ingredients, and potential risks to public health.

This classification system serves several important purposes: protecting public health by ensuring appropriate controls are in place for different types of pharmaceutical products, establishing clear regulatory requirements for manufacturers, importers, distributors, and healthcare providers, and preventing misuse or inappropriate handling of potentially harmful substances while maintaining access to necessary medications.

Definition of Pharmaceutical Products

Under the Pharmacy and Poisons Ordinance, pharmaceutical products are defined as substances or preparations intended for use in the diagnosis, treatment, mitigation, or prevention of disease, or for affecting the structure or function of the body of humans or animals. This definition encompasses a wide range of products, including:

• Prescription medicines
• Over-the-counter medications
• Traditional Chinese medicines incorporated into Western pharmaceutical formulations
• Medical devices with a pharmaceutical component
• Diagnostic reagents and substances
• Vitamins and minerals presented with therapeutic claims

Classification Categories

The Pharmacy and Poisons Ordinance establishes a stratified classification system for pharmaceutical products based on their potential risks and therapeutic requirements. The main categories include:

1. Registered Pharmaceutical Products

These are products that have undergone evaluation by the Pharmacy and Poisons Board and have been included in the Register of Pharmaceutical Products. This category includes:

• Prescription medicines requiring authorization by a registered medical practitioner
• Pharmacy-only medicines available for sale under pharmacist supervision
• General sales list medicines available without professional supervision

2. Poisons

Products containing substances with potentially harmful effects are further classified into three schedules based on their toxicity and potential for misuse:

• Schedule 1 Poisons: Highly restricted substances with serious abuse potential, including certain narcotics and dangerous drugs
• Schedule 2 Poisons: Medicinal poisons requiring professional dispensing (available only on prescription)
• Schedule 3 Poisons: Medicinal poisons available without prescription but requiring pharmacist supervision

3. Dangerous Drugs

These are substances with recognized potential for abuse or dependence, regulated under both the Pharmacy and Poisons Ordinance and the Dangerous Drugs Ordinance (Cap. 134). Their classification takes into account factors such as:

• Pharmacological effects
• Risk of dependence
• International control status
• Legitimate medical uses

Determination of Classification

The classification of a product as a pharmaceutical product and its placement within appropriate schedules is determined through a comprehensive evaluation process that considers several factors:

1. Pharmacological Activity: The product's intended effect on bodily systems or specific diseases, including its mode of action and therapeutic potential.
2. Ingredients and Composition: Analysis of active ingredients, concentrations, formulation, and the presence of any potentially harmful substances.
3. Intended Use: The claimed therapeutic purpose as indicated on labeling, packaging, or promotional materials, which must be supported by scientific evidence.
4. Safety Profile: Evaluation of potential adverse effects, toxicity studies, contraindications, and risk-benefit ratio.
5. Dosage Form: The physical form of the product (tablets, injections, creams, etc.) as this may affect safety and appropriate use.
6. Potential for Misuse: The likelihood of abuse, dependence, or inappropriate use, particularly for products containing psychoactive ingredients.

Regulatory Requirements by Classification

Each classification category carries specific regulatory requirements for different stakeholders in the pharmaceutical supply chain:

For Manufacturers

• Good Manufacturing Practice (GMP) certification
• Product registration for all pharmaceutical products
• Licensing for premises manufacturing controlled substances
• Quality assurance procedures and documentation
• Post-marketing surveillance and adverse event reporting

For Importers/Exporters

• Licenses for handling scheduled poisons
• Record-keeping requirements for controlled substances
• Compliance with import/export permit systems
• Storage conditions appropriate to the product classification

For Wholesale Distributors

• Wholesale dealer licenses
• Adequate storage facilities meeting temperature and security requirements
• Traceability systems for product tracking
• Sales restrictions based on product classification

For Retail Pharmacies

• Retail pharmacy licenses
• Qualified pharmacist supervision for dispensing of prescription medications and Schedule 3 poisons
• Patient counseling capabilities
• Record-keeping for dispensed controlled substances

Registration Process

The registration of pharmaceutical products under Cap. 138 involves a multi-step process to ensure safety, quality, and efficacy:

1. Pre-submission Preparation: Compilation of required documentation including:
• Product composition and manufacturing process details
• Preclinical and clinical study data
• Quality control specifications and methods
• Sample products and reference standards
• Proposed labeling and packaging information
2. Application Submission: Submitting a completed application form with supporting documents to the Pharmacy and Poisons Board through the Drug Office of the Department of Health.
3. Evaluation: Thorough review of the application by regulatory assessors covering quality, safety, and efficacy aspects. This may include:
• Chemistry, manufacturing, and controls assessment
• Preclinical and clinical data review
• Risk-benefit analysis
• Classification determination
4. Expert Committee Review: Reference to the Advisory Committee on Pharmaceuticals or other expert bodies for complex or novel products.
5. Approval and Registration: Successful applications are added to the Register of Pharmaceutical Products with assigned classification and any specific conditions.

Exemptions and Special Cases

Certain products are subject to special regulatory considerations or exemptions under the ordinance:

• Professional Samples: Medicinal products provided for professional evaluation are subject to specific regulatory controls.
• Personal Importation: Limited quantities may be imported for personal use under strict conditions.
• Clinical Trial Supplies: Products used in approved clinical trials receive special classification and handling requirements.
• Emergency Supplies: Products imported for treatment of rare diseases or special circumstances may be granted special approval.
• Hospital Compounded Preparations: Products prepared within hospital pharmacies according to specific prescriber instructions may have modified classification status.

Compliance and Enforcement

The Pharmacy and Poisons Ordinance establishes robust compliance and enforcement mechanisms to ensure adherence to classification and regulatory requirements:

• Regular Inspections: Scheduled inspections of licensed premises by regulatory officers.
• Product Sampling: Random sampling of pharmaceutical products for quality testing and verification of compliance with registered specifications.
• Record Checks: Audit of transaction records, particularly for controlled substances.
• Market Surveillance: Monitoring of pharmaceutical products in circulation for quality issues or irregularities.
• Enforcement Actions: Penalties for non-compliance may include:
• License suspension or revocation
• Fines and prosecutions
• Product recall or seizure
• Warning letters

Recent Developments

The classification system under the Pharmacy and Poisons Ordinance continues to evolve to address emerging challenges in healthcare and pharmaceuticals:

• Digital Health Products: Development of frameworks for classifying software-based therapeutic devices and digital therapeutics.
• Biologics and Advanced Therapies: Establishment of specialized pathways for biological products, gene therapies, and regenerative medicines.
• International Harmonization: Alignment of classification criteria with international regulatory standards to facilitate global access to medicines.
• Risk-Based Regulation: Implementation of more proportional regulatory approaches that focus resources on higher-risk products.

Conclusion

The classification of products under Hong Kong's Pharmacy and Poisons Ordinance represents a comprehensive regulatory framework designed to protect public health while ensuring access to safe, effective, and quality pharmaceutical products. This stratified system allows for appropriate control measures proportionate to the risks posed by different products.

For stakeholders in the pharmaceutical industry, understanding this classification system is essential for compliance with regulatory requirements. For healthcare professionals and consumers, awareness of these classifications helps ensure proper handling, dispensing, and use of medications.

As pharmaceutical science continues to advance with novel therapies and treatment modalities, the classification system will undoubtedly continue to evolve, maintaining its critical role in safeguarding public health in Hong Kong's healthcare landscape.